Elecsys Anti-SARS-CoV-2 by Roche Diagnostics

Manufacturer Roche Diagnostics  |  Available Worldwide
5.0
/
5.0
  |  1 reviews
Immunoassay for the qualitative detection of antibodies (incl. IgG) against SARS-CoV-2


Elecsys Anti-SARS-CoV-2 by Roche Diagnostics product image
Elecsys Anti-SARS-CoV-2

Roche Diagnostics

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 5.0
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2019

  • Organization: Hospital Clínic



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Fast option to detect during the pandemic.
Rating: 5.0

  • Application Area: Human immunization (Ig) by anti-SARS-CoV-2

"The product allows the automation of human Ig anti-SARS-CoV-2 detection."

Review date: 24 Dec 2020 | Elecsys Anti-SARS-CoV-2

Immunoassay to qualitatively detect antibodies (including IgG) against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Elecsys® Anti-SARS-CoV-2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to SARS-CoV-2 in human serum and plasma. The assay uses a recombinant protein representing the nucleocapsid (N) antigen in a double-antigen sandwich assay format, which favors detection of high affinity antibodies against SARS-CoV-2. Elecsys® Anti-SARS-CoV-2 detects antibody titers, which have been shown to positively correlate with neutralizing antibodies in neutralization assays. The test is intended as an aid in the determination of the immune reaction to SARS-CoV-2.